Lung cancer remains one of the most prevalent and deadly forms of cancer worldwide. The key to improving patient outcomes lies in early detection and accurate prognosis. Recent advancements in the field of biomarkers have brought forth a promising era in lung cancer research. These breakthrough biomarkers offer a glimmer of hope, enabling precise early detection and prognosis, ultimately leading to improved patient management and survival rates. Lung cancer continues to be a major global health concern, accounting for a significant number of cancer-related deaths. Early detection and accurate prognosis play pivotal roles in improving patient outcomes and survival rates. In recent years, the field of lung cancer research has witnessed remarkable advancements in the discovery of novel biomarkers. These emerging biomarkers hold immense promise in facilitating early diagnosis and providing valuable prognostic information, revolutionizing the management of lung cancer patients.
HTML PDFShare this article
